Navigation Links
Gen-Probe Launches Cash Tender Offer to Acquire Belgian Molecular Diagnostics Company Innogenetics
Date:6/3/2008

is acting as financial adviser to Gen-Probe on this transaction, and Linklaters and Cooley Godward Kronish are serving as legal counsel.

Webcast Conference Call

Gen-Probe will discuss the proposed acquisition with analysts and investors on a conference call at 8:30 a.m. Eastern Time today. A live webcast of the call can be accessed at http://www.gen-probe.com. The webcast will be archived for at least 90 days. A telephone replay of the call also will be available for approximately 24 hours. The replay number is (800) 282-5736 for domestic callers and (402) 220-9727 for international callers.

About Innogenetics

Innogenetics NV is an international biotechnological company headquartered in Gent, Belgium that develops and markets diagnostic products to improve therapy management and patient health. Innogenetics' diagnostics business unit develops and markets a wide range of diagnostic assays with a focus on molecular diagnostics and multiparameter testing. Its products are sold in over 90 countries through its six subsidiaries and a large number of distributors. In 2007, diagnostics product sales totaled EUR 47 million, more than 95% of which were achieved outside Belgium. Founded in 1985, Innogenetics is listed on Euronext Brussels [EBR: INNX].

On April 25, Innogenetics and Solvay announced the launch of an offer by Solvay to acquire all the outstanding shares, warrants and convertible bonds of Innogenetics.

About Gen-Probe

Gen-Probe Incorporated is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) that are used primarily to diagnose human diseases and screen donated human blood. Gen-Probe has approximately 25 years of NAT expertise, and received the 2004 National Medal of Technology, America's highest honor for technological innovation, for developing NAT assays for blood screening. Gen-Probe
'/>"/>

SOURCE Gen-Probe Incorporated
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Gen-Probe to Webcast Presentation at Bank of Americas 37th Annual Investment Conference
2. Gen-Probe Reports Strong Financial Results for Third Quarter 2007, Raises Full-Year Guidance for Earnings Per Share and Total Revenues
3. Gen-Probe to Webcast Three Upcoming Presentations
4. Gen-Probe Announces Webcast of Fourth Quarter and Full Year 2007 Earnings Conference Call
5. Carl Hull Named President and Chief Operating Officer of Gen-Probe
6. Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007
7. Gen-Probe to Webcast Presentations at Lehman and Cowen Healthcare Conferences
8. Gen-Probe to Webcast Presentation at Morgan Stanley Global Healthcare Unplugged Conference
9. Gen-Probe Reports Strong Financial Results for First Quarter 2008, Raises Full-Year Guidance
10. Gen-Probe to Webcast Presentation at Deutsche Bank 33rd Annual Health Care Conference
11. Lucy Shapiro, Ph.D., Elected to Gen-Probe Board of Directors

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)... -- Intarcia Therapeutics, Inc. delivered two pres...nuous delivery of exenatide) program for the treat...es Technology Meeting in San Francisco, CA: ,, ...01/SFTU126LOGO ) ,, Continuous Subcutaneous D...ucose, HbA1c and Reduces Weight in a 28-day Phase ...
(Date:11/5/2009)... , Fuel economy ratings for the new 2010 model y...nomy.gov web site, which Oak Ridge National Labor...ent of Energy and the U.S. Environmental Protectio...fuel economy list are hybrid electrics, led by the...t proves that hybrids have gone mainstream," said ...
(Date:11/5/2009)...e/ -- The endangered black-footed ferrets inhabit ...arnivore feeds on prairie dogs. The prairie dogs...opulation die-offs in towns occur. The U.S. Fish ...ret breeding program and has been releasing traine...tat. Unfortunately, plague can sweep through and ...
(Date:11/5/2009)...all/ -- Imagenetix, Inc. (OTC Bulletin Board: IAGX... and CEO of Imagenetix, will be presenting the Com... on Thursday, December 3rd, at 10:30 AM PST at the...,, LD MICRO is a by-invitation only newsletter ... in the micro-cap space. Since 2002, the firm has ...
Breaking Biology Technology:Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2
...n of the Board -, MADISON, N.J., April 24 Wyeth ...obert Essner, 60, has decided to retire,from the C...d the position,of Chairman since January 2003 and ...1 to 2007. The Company,s Board of Directors has el... Executive Officer, to the,additional position of ...
...Inc.,(Nasdaq: HOLX ), a diversified medical techn...imaging products and interventional devices dedica...y announced plans to release its,second quarter fi...08 at,8:00 a.m. (eastern). In conjunction with the...n Thursday, May 1, 2008 at 9:00 a.m. (eastern)., ...
...ewswire-FirstCall/ -- China Sky One,Medical, Inc. ...lletin,Board: CSKI), a pharmaceutical company for ...s Republic of China ("PRC"), today announced it,ac...ina Pharmaceutical"), a,recently formed corporatio... 2008., China Sky One Medical, Inc., through its ...
Other Biology Technology:Wyeth Chairman Robert Essner Announces June 27 Retirement 2Hologic, Inc. to Release Second Quarter Fiscal 2008 Operating Results Thursday, May 1st Before Market Opens 2China Sky One Medical, Inc. Acquires Heilongjiang Haina Pharmaceutical Inc. 2China Sky One Medical, Inc. Acquires Heilongjiang Haina Pharmaceutical Inc. 3
(Date:11/9/2009)...e of butterfly wings has inspired a 3.2m, three-ye...ation in the fields of security, energy and the en...nal technology company QinetiQ have just signed a ... based on groundbreaking physical sciences researc...ists from the University of Exeter and QinetiQ wil...
(Date:11/9/2009)...rlands, November 09, 2009 / b3c newswire / - To...and Seventh Wave, an American organization for con...companies have signed a letter of intent with rega...els TIM. The letter of intent proposes a collabora...tems for commercialization in North America. The T...
(Date:11/9/2009)...cientists and industry leaders from around the wor... AACR-NCI-EORTC Molecular Targets and Cancer Thera...re groundbreaking information on important cancer ...x disease and to treat it effectively we need a gr...ce at the molecular level," said Lewis Cantley, Ph...
Breaking Biology News(10 mins):£3.2m ($5.4 million) research project to capture brilliance of butterfly wings 2TNO and Seventh Wave sign letter of intent on joint preclinical pharmaceutical outsourcing services 2Take A Swing Against Breast Cancer 21 51913 1Take A Swing Against Breast Cancer 21 51913 2ANDRES F ALONSO ESQ a Partner in the Law Firm of PARKER WAICHMAN ALONSO LLP Was Appointed Co Lead Counsel to the Plaintiffs Steering Committee in 51908 1ANDRES F ALONSO ESQ a Partner in the Law Firm of PARKER WAICHMAN ALONSO LLP Was Appointed Co Lead Counsel to the Plaintiffs Steering Committee in 51908 2Mettler Toledo International Inc to Host Second Quarter 2009 Earnings Conference Call 51904 1
...NY, October 30, 2008 Bayhill Therapeutics, Inc., ...seases, and the Juvenile Diabetes Research Foundat... 1 diabetes research, today announced a partnershi...inical trial of BHT-3021, a DNA vaccine to reverse..., BHT-3021 is an antigen-specific immunotherapeut...
...raits that we look for typically include a sense o...isma. However, a recent study suggests that it is ...cation skills that determine who is chosen as lead...at there is a gender bias when selecting leaders; ...end on the specific situation that a group finds i...
...rs at Georgetown University Medical Center have di...become resistant to tamoxifen, the world,s largest...ug. They say the findings could provide a way to i...ng from the drug, allowing doctors to try another ...f the journal Cancer Research, the researchers s...
Other Biology News:Bayhill Therapeutics and the Juvenile Diabetes Research Foundation announce research collaboration 2Bayhill Therapeutics and the Juvenile Diabetes Research Foundation announce research collaboration 3Gender biases in leadership selection during competitions within and between groups 2Gender biases in leadership selection during competitions within and between groups 3'New' estrogen receptor found to be key player in tamoxifen resistance 2'New' estrogen receptor found to be key player in tamoxifen resistance 3
...e a group of enzymes involved in matrix degradatio...ase family ten exist in soluble form whereas MT-MM...T2-MMP, MT3-MMP also known as MMP14, MMP15, MMP16 ...main anchoring them to the cell surface. They have...
CD43 MicroBeads, rat from Miltenyi Biotec
... IKATUBE ULTRA TURRAX Tube Disperser System from I...ystem. It offers a cleaner, safer, and more effici...ocesses sample volumes from 2 to 15 ml inside seal...ers can choose one of 4 different tube types. Each...
RNaseAlert Lab Test Kit from Ambion
Biology Products: